Supplementary Figures Supplementary Fig. S1 Schematic representation of CP phosphorylation mutations incorporated into the infectious BBSV cDNA clone (pUBF52).
PKA phosphorylation of CP at T41 and S15.
In vitro phosphorylation of rCP wt and CP mutants showing that S15 and T41 are phosphorylated by commercial PKA. His-tagged CP wt , CP S12A , CP S15A , CP T18A , CP R39A , CP T41A , and CP S12/S15/T18/T41A were phosphorylated in vitro by PKA and autoradiographed (top panel, lanes 3-9, arrowhead). Reactions lacking rCP (lane 1) or PKA (lane 2) served as negative controls. Equal loading is indicated at the bottom panel.
Supplementary Fig. S3 In vitro assembly of virus-like particles from rCP wt and BBSV in vitro transcripts.
Phosphorylated rCP wt and in vitro BBSV transcripts were mixed and subjected to in vitro assembly (C) as described in the supplementary methods below. Assembly of non-phosphorylated rCP wt with (B) or without (A) RNA served as control.
Subsequently, the samples were concentrated and observed under TEM and the sizes of 50 particles were measured.
Supplementary Methods

In vitro assembly of virus-like particles
Recombinant CP wt (rCP wt ) was purified from E. coli and subjected to in vitro PKA phosphorylation as described in the text of the primary paper. Subsequent assembly reactions used minor modifications of the procedure of Cadena-Nava et al. 1 . Briefly, 300 μg of phosphorylated rCP wt was mixed at a ratio of 6:1 (wt/wt) with purified in vitro BBSV transcripts (50 μg). The reaction mixtures were then dialyzed overnight at 4°C against assembly buffer (50 mM Tris-HCl, pH 7.2, 10 mM KCl, 5 mM MgCl 2 , 1 mM DTT). The overnight dialysis was then followed by dialysis for 6 hours at 4°C in reassembly buffer (50 mM sodium acetate, pH 4.8, 5 mM MgCl 2 , 1 mM DTT).
The assembled particles were subjected to five washes in involving resuspension in reassembly buffer and centrifugation (3000 g) at 4°C with a Amicon-Ultra-0.5 filter (100 kDa, Millipore) 1 . CKIIsub CKIIsub-F GACGACGACGACGACTAGCTGGTTCCGCGTGGATCCCCG Insert peptide "RRADDSDDDDD" followed GST-tag using reverse PCR CKIIsub-R ACTATCATCAGCGCGGCG ATCCGATTTTGGAGGATGGTCGCC
PKAsub
PKAsub-F AGCCTCGGA TAG CTGGTTCCGCGTGGATCCCCG Insert peptide "LRRASLG" followed GST-tag using reverse PCR PKAsub-R AGCACGTCGC AG ATCCGATTTTGGAGGATGGTCGCC
CaMKIIsub
CaMKIIsub-F GAGACTGTAGACGCACTGTAGCTGGTTCCGCGTGGATCCCCG Insert peptide "KKALRRQETVDAL" followed GST-tag using reverse PCR CaMKIIsub-R TTGCCGTCGGAGAGCCTTCTTATCCGATTTTGGAGGATGGTCGCC a F, forward primer; R, reverse primer. b Restriction sites are underlined.
